Business Context and Reporting Period
This Form 8-K, dated May 8, 2023 and signed May 9, 2023, was filed by MultiPlan Corporation, not Claritev Corp. The filing reports the completion of MultiPlan’s acquisition of Benefits Science LLC, doing business as Benefits Science Technologies (BST).
Transaction and Key Financial Terms
- MultiPlan acquired 100% of BST through its wholly owned indirect subsidiary, Babylon Acquisition Corp.
- Total consideration was $160.0 million, consisting of approximately $140.8 million in cash, subject to customary closing adjustments, and 21,588,658 shares of MultiPlan Class A common stock.
- The stock issuance was unregistered and made in reliance on the Securities Act Section 4(a)(2) exemption. MultiPlan is required to file a shelf registration statement covering resale of the shares issued to sellers.
- BST became a wholly owned indirect subsidiary of MultiPlan upon closing.
Material Changes Versus the Prior Comparable Period
The filing does not provide current-period revenue, profit, cash flow, margin, debt, liquidity, or operating results for MultiPlan or BST, and therefore does not quantify changes versus a prior comparable period. It does provide audited BST financial statements for the years ended December 31, 2022 and 2021 and unaudited pro forma combined financial information for the year ended December 31, 2022 as exhibits.
Guidance, Outlook, Risks, and Unusual Items
- MultiPlan will establish a long-term incentive and retention program for certain BST founders, employees, service providers, and other MultiPlan employees.
- Potential aggregate cash payments under the program are $66.0 million at target annual recurring revenue achievement, plus up to $16.5 million for maximum achievement. Payments depend on continued employment or engagement and achievement of BST annual recurring revenue targets over five years, weighted toward 2024–2026.
- The filing contains forward-looking statements regarding the acquisition and its expected impact. Management cautions that actual results may differ materially because of risks described in MultiPlan’s 2022 Form 10-K and other factors beyond its control.
- The acquisition consideration, unregistered stock issuance, future resale registration, and contingent incentive payments are the principal unusual or material items disclosed.
Important Facts for Investors to Verify
- Confirm the intended registrant: the provided filing identifies MultiPlan Corporation, while the request metadata identifies Claritev Corp.
- Review BST’s audited 2021 and 2022 financial statements and the pro forma combined financial information filed as exhibits.
- Assess the final cash consideration after working capital, cash, indebtedness, and transaction-expense adjustments.
- Evaluate dilution from the issuance of 21,588,658 Class A shares and the timing and terms of the required resale registration statement.
- Review the potential $82.5 million maximum incentive and retention obligation and the annual recurring revenue targets governing payment.
- Consider acquisition integration risks and the forward-looking statement risk factors incorporated from MultiPlan’s 2022 Form 10-K.